ANDA 40410, held by Watson Laboratories. Methylphenidate Hydrochloride.
As of Nov 21, 2026, ANDA 40410 (Methylphenidate Hydrochloride), held by Watson Laboratories, was first approved by FDA on Feb 9, 2001, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 9, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methylphenidate Hydrochloride20MG · tablet, extended release;oral | Methylphenidate Hydrochloride | Discontinued |
| Sep 23, 2008 | Supplement 9Labeling | Approved | None posted |
| Jan 21, 2003 | Supplement 4Labeling | Approved | None posted |
| Sep 17, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Feb 9, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters